Insider · CIK 0001738830
Ademir Sarcevic
Files at SXI (STANDEX INTERNATIONAL CORP/DE/), CLFD (Clearfield, Inc.). First filing Nov 6, 2024, latest Nov 5, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SXI: STANDEX INTERNATIONAL CORP/DE/
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | STANDEX INTERNATIONAL CORP/DE/ | $420k 1,823 shares | -16% | +76% from low-6% from high | |
| 50Moderate | STANDEX INTERNATIONAL CORP/DE/ | $228k 1,085 shares | -9% | +61% from low-0% from high | |
| 61Notable | STANDEX INTERNATIONAL CORP/DE/ | $584k 3,047 shares | -21% | +48% from low-8% from high | |
| 44Moderate | STANDEX INTERNATIONAL CORP/DE/ | $320k 1,600 shares | -8% | - | |
| 56Moderate | STANDEX INTERNATIONAL CORP/DE/ | $690k 3,800 shares | -16% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | CLFD Clearfield, Inc. | AGrant or award Common Stock | +2,544 | $0.00 | $0 | 5,317 | Mar 2, 2026 |
| Nov 4, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | SOpen-market sale Common Stock | -1,823 | $230.12 | $420k | 9,341 | Nov 5, 2025 |
| Aug 26, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | SOpen-market sale Common Stock | -1,085 | $209.86 | $228k | 11,164 | Aug 28, 2025 |
| Aug 22, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | MOption exercise Common Stock | +1,912 | $210.48 | $402k | 13,235 | Aug 26, 2025 |
| Aug 22, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | FTax withholding Common Stock | -753 | $210.48 | $158k | 12,482 | Aug 26, 2025 |
| Aug 22, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | FTax withholding Common Stock | -483 | $210.48 | $102k | 11,999 | Aug 26, 2025 |
| Aug 22, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | FTax withholding Common Stock | -327 | $210.48 | $69k | 11,672 | Aug 26, 2025 |
| Aug 22, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | MOption exercise Common Stock | +952 | $210.48 | $200k | 12,624 | Aug 26, 2025 |
| Aug 22, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | FTax withholding Common Stock | -375 | $210.48 | $79k | 12,249 | Aug 26, 2025 |
| Aug 22, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | MOption exercise Phantom Stock Unitsderivative | -1,912 | $0.00 | $0 | 1,765 | Aug 26, 2025 |
| Aug 22, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | MOption exercise Restricted Stock Unitsderivative | -952 | $0.00 | $0 | 1,904 | Aug 26, 2025 |
| Aug 23, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | AGrant or award Phantom Stock Unitsderivative | +2,490 | $0.00 | $0 | 2,490 | Aug 26, 2025 |
| Aug 23, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | AGrant or award Restricted Stock Unitsderivative | +2,490 | $0.00 | $0 | 2,490 | Aug 26, 2025 |
| Aug 23, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | DDisposition to issuer Phantom Stock Unitsderivative | -1,765 | $0.00 | $0 | 0 | Aug 26, 2025 |
| Aug 6, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | SOpen-market sale Common Stock | -3,047 | $191.80 | $584k | 11,323 | Aug 7, 2025 |
| Apr 1, 2025 | SXI STANDEX INTERNATIONAL CORP/DE/ | FTax withholding Common Stock | -1,716 | $160.58 | $276k | 14,370 | Apr 3, 2025 |
| Feb 28, 2025 | CLFD Clearfield, Inc. | AGrant or award Common Stock | +2,468 | $0.00 | $0 | 2,773 | Mar 3, 2025 |
| Dec 11, 2024 | CLFD Clearfield, Inc. | AGrant or award Common Stock | +305 | $0.00 | $0 | 305 | Dec 13, 2024 |
| Nov 20, 2024 | SXI STANDEX INTERNATIONAL CORP/DE/ | SOpen-market sale Common Stock | -1,600 | $199.81 | $320k | 18,086 | Nov 22, 2024 |
| Nov 4, 2024 | SXI STANDEX INTERNATIONAL CORP/DE/ | SOpen-market sale Common Stock | -3,800 | $181.64 | $690k | 19,686 | Nov 6, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.